The Safety Controls IPO is a ₹48 crore book-built issue, consisting entirely of a fresh…

GSP Crop Science IPO GMP, Price & Key Details 2026
The GSP Crop Science IPO is one of the latest mainboard IPOs in 2026, attracting attention from investors due to its strong presence in the agrochemical sector. The company manufactures products like insecticides, herbicides, and fungicides, helping farmers improve crop productivity.

This IPO opened on March 16, 2026, and will close on March 18, 2026. The company aims to raise around ₹400 crore, which will be used mainly for debt repayment and general corporate purposes.
Talking about pricing, the IPO comes with a price band of ₹304 to ₹320 per share, making it accessible for retail investors as well.

GSP Crop Science IPO – Key Details
| Particulars | Details |
|---|---|
| IPO Open Date | March 16, 2026 |
| IPO Close Date | March 18, 2026 |
| Price Band | ₹304 – ₹320 per share |
| Face Value | ₹10 per share |
| Issue Size | Approx ₹400 Crore |
| Lot Size | 46 Shares |
| Listing Date | March 24, 2026 |
| Listing Exchange | BSE & NSE |
GMP (Grey Market Premium) Update
As per the latest updates, the GMP (Grey Market Premium) of GSP Crop Science IPO is currently around ₹0, which indicates a flat listing expectation.
| Date | IPO GMP | GMP Trend | Gain |
|---|---|---|---|
| 17 March | ₹- | – | -% |
| 16 March | ₹- | – | -% |
| 14 March | ₹- | – | -% |
This suggests that the market sentiment is neutral right now, and investors are advised to carefully analyze fundamentals before investing.
About the Company
GSP Crop Science is a research-driven agrochemical company with over 40 years of experience. It operates multiple manufacturing units and exports its products to several countries, including the US and Brazil.
The company focuses on crop protection solutions and aims to support sustainable agriculture.
Final Thoughts
The IPO looks decent in terms of fundamentals, but the zero GMP indicates cautious market sentiment. Investors should consider long-term potential rather than short-term listing gains.